Home/Filings/4/0000905148-24-000999
4//SEC Filing

SCHACHLE JOSEPH K 4

Accession 0000905148-24-000999

CIK 0001228627other

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 4:44 PM ET

Size

14.9 KB

Accession

0000905148-24-000999

Insider Transaction Report

Form 4
Period: 2024-03-21
SCHACHLE JOSEPH K
Chief Operating Officer
Transactions
  • Purchase

    Common Stock

    2024-03-21$2.05/sh+2,000$4,1002,000 total

Issuer

Ocuphire Pharma, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001145914

Filing Metadata

Form type
4
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 4:44 PM ET
Size
14.9 KB